06 August 2018
Visiongain’ has launched a new pharma report Global Infusion Devices Market Forecast to 2027 Infusion Pumps, Insulin Pumps, Enteral Feeding Pumps, other Infusion Pumps
Infusion pumps have been a reliable source of drug delivery for nearly a century. These infusion devices can be used to treat a wide range of therapeutic areas including analgesia, chemotherapy, diabetes and clinical nutrition, thus making them an invaluable tool in modern medicine. With the advent of modern medical devices the infusion pump market has become one of the fastest growing drug delivery segments within the market. This rapid growth is projected due to the nature of the illnesses which infusion pumps are used to treat.
The lead analyst of the report commented “Visiongain has identified several issues and trends impacting the future of the infusion pumps market. Ageing populations, increasing incidence of diseases - particularly diabetes, and increasing healthcare coverage in developing countries will continue to fuel market growth in the future.
Key issues and trends explored in this report include: increasing life expectancy worldwide, growing incidence of disease, worldwide spending on healthcare, infusion pump health risks and recalls, new regulations in leading national markets, smart pump technology and a shift from hospital to home health care.”
Leading companies featured in the report include ALCOR Scientific, Altea Therapeutics, Animas Corporation, B.Braun, Baxter, CareFusion, Cellnovo, Covidien, D. Medical Industries, Danone Nutricia, Debiotech, Disetronic (Roche), Fresenius Kabi, Hospira, Insulet CorporationJohnson & Johnson, Medline, MedSolve Technologies, Medtronic, Q Core Medical, Roche, Smiths Medical
SOOIL, Tandem Diabetes Care, Valeritas, Zevex
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.
19 April 2021
The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.
12 April 2021
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.
09 April 2021
The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.